Cost Effectiveness Analysis of The Use Of Daclatasvir + Asunaprevir in The Treatment of Patients with Chronic Hepatitis C in Peru

Value in Health ◽

10.1016/j.jval.2017.08.2910 ◽

2017 ◽

Vol 20 (9) ◽

pp. A930

Author(s):

C Sanabria ◽

R Roman ◽

D Montano ◽

D Mercado ◽

G Valenzuela ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis

Download Full-text

PGI18 Treatment of Chronic Hepatitis C Patients with Peginterferon Alfa-2a or Peginterferon Alfa-2b: A Cost-Effectiveness Analysis for the Portuguese NHS Setting

Value in Health ◽

10.1016/j.jval.2011.08.889 ◽

2011 ◽

Vol 14 (7) ◽

pp. A394-A395

Author(s):

J. Areias ◽

T. Branco ◽

F. Calinas ◽

A. Carvalho ◽

G. Macedo ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Peginterferon Alfa ◽

Chronic Hepatitis C Patients

Download Full-text

Management of treatment-naïve chronic hepatitis C genotype 1 patients: a cost-effectiveness analysis of treatment options

Journal of Viral Hepatitis ◽

10.1111/jvh.12278 ◽

2014 ◽

Vol 22 (2) ◽

pp. 175-183 ◽

Author(s):

P. A. Cortesi ◽

A. Ciaccio ◽

M. Rota ◽

J. K. Lim ◽

S. De Salvia ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Treatment Options ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Treatment Naïve

Download Full-text

Cost-Effectiveness Analysis Of Daclatasvir With Asunaprevir In Treatment Of Chronic Hepatitis C In The Russian Federation

Value in Health ◽

10.1016/j.jval.2016.09.397 ◽

2016 ◽

Vol 19 (7) ◽

pp. A415

Author(s):

R Yagudina ◽

A Kulikov ◽

VV Babiy

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Russian Federation ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

The Russian Federation

Download Full-text

Cost-effectiveness analysis of treatment with peginterferon-alfa-2a versus peginterferon-alfa-2b for patients with chronic hepatitis C under the public payer perspective in Brazil

Cost Effectiveness and Resource Allocation ◽

10.1186/1478-7547-11-25 ◽

2013 ◽

Vol 11 (1) ◽

pp. 25 ◽

Author(s):

Fabio MR Barros ◽

Hugo Cheinquer ◽

Carolina T Tsuchiya ◽

Eduardo AV Santos

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Payer Perspective ◽

Public Payer ◽

Peginterferon Alfa

Download Full-text

PIN42 Cost-Effectiveness-Analysis of the Combination- Therapy Telaprevir, Peg-IFNα2a and Ribavirin in Patients With Chronic Hepatitis-C in Austria

Value in Health ◽

10.1016/j.jval.2012.08.1109 ◽

2012 ◽

Vol 15 (7) ◽

pp. A392

Author(s):

M. Said ◽

A. Dragosits ◽

E. Walter

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis

Download Full-text

PIN8 COST-EFFECTIVENESS ANALYSIS OF PEGINTERFERON (ALFA-2B) WITH RIBAVIRIN COMPARED WITH PEGINTERFERON (ALFA-2A) WITH RIBAVIRIN FOR THE TREATMENT OF CHRONIC HEPATITIS C

Value in Health ◽

10.1016/s1098-3015(11)72807-8 ◽

2010 ◽

Vol 13 (7) ◽

pp. A431

Author(s):

VV Omelyanovsky ◽

MV Avksentieva ◽

I Krysanov ◽

O Ivakhnenko

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Peginterferon Alfa

Download Full-text

Cost-Effectiveness Analysis of Sofosbuvir Compared to Current Standard Treatment in Swiss Patients with Chronic Hepatitis C

PLoS ONE ◽

10.1371/journal.pone.0126984 ◽

2015 ◽

Vol 10 (5) ◽

pp. e0126984 ◽

Author(s):

Alena M. Pfeil ◽

Oliver Reich ◽

Ines M. Guerra ◽

Sandrine Cure ◽

Francesco Negro ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Standard Treatment ◽

Cost Effectiveness Analysis ◽

Current Standard ◽

Effectiveness Analysis ◽

Current Standard Treatment

Download Full-text

Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.12871 ◽

2014 ◽

Vol 40 (6) ◽

pp. 657-675 ◽

Author(s):

S. Saab ◽

S. C. Gordon ◽

H. Park ◽

M. Sulkowski ◽

A. Ahmed ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Virus Genotype ◽

Effectiveness Analysis ◽

Chronic Hepatitis C Virus

Download Full-text

Ledipasvir / Sofosbuvir for The Treatment of Chronic Hepatitis C: A Cost-Effectiveness Analysis Across Different Genotype 1 Clinical Subgroups

Value in Health ◽

10.1016/j.jval.2015.09.1966 ◽

2015 ◽

Vol 18 (7) ◽

pp. A585 ◽

Author(s):

J Félix ◽

J Almeida ◽

D Ferreira ◽

M Mota ◽

M Afonso-Silva ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis

Download Full-text

Cost-Effectiveness Analysis of Boceprevir for the Treatment of Chronic Hepatitis C Virus Genotype 1 Infection in Portugal

Applied Health Economics and Health Policy ◽

10.1007/s40258-012-0007-8 ◽

2013 ◽

Vol 11 (1) ◽

pp. 65-78 ◽

Author(s):

Elamin H. Elbasha ◽

Jagpreet Chhatwal ◽

Shannon A. Ferrante ◽

Antoine C. El Khoury ◽

Pedro A. Laires

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Virus Genotype ◽

Effectiveness Analysis ◽

Chronic Hepatitis C Virus

Download Full-text